• Home
  • Investors
    • News Archive
    • Share Information
      • Shareholder Service
      • General Meetings
    • Reports
    • Board and Management
  • Contact

You are here

Home » Investors

News

Disclosure of shareholding
Allotment of shares to primary insiders
Flagging
NorDiag receives NOK 9,4 Million in public funding
New distributor in Italy
Commencement of subscription period for rights issue
NORD T - listed tomorrow
Allotment of options and warrants
Roadshow presentation
New distributor for Benelux and Spain
New sales & marketing manager for Europe
Trading exclusive of subscription rights as of today
Extraordinary general meeting held in NorDiag ASA
NorDiag ASA CE IVD labels its high throughput instrument (Bullet)
Calendar of Finance 2009
Proposal for rights issue etc.
Notice of extraordinary general meeting in NorDiag ASA
Successful completion of NorDiag's clinical trial tailored to the BD Probetec (TM) ET system
NorDiag Q3: Successful outcome of clinical trial
Roche Diagnostics Scandinavia AB and NorDiag ASA sign new collaboration agreement

Pages

  • « first
  • ‹ previous
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • next ›
  • last »
News archive

NORDA ASA  ♦  Stortingsgaten 28  ♦   0161 Oslo  ♦   Norway  ♦   Phone: +47 924 23 561  ♦   web: www.nordasa.no